Results 71 to 80 of about 35,256 (161)

Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-CD20 monoclonal antibody: a systematic review and meta-analysis of prognostic factors. [PDF]

BMC Cancer, 2022
Mkhwanazi ZA, Nyambuya TM, Mfusi SA, Nkambule BB.   +3 more
europepmc   +1 more source

Anti-CD20 Monoclonal Antibody-FITC [PDF]

, 2020
openaire   +1 more source

Hemagophagocytic lymphohistiocytosis associated with recurrent Babesiosis with Lyme disease co-infection in an immunocompromised host on anti-CD20 monoclonal antibody therapy: A case report. [PDF]

IDCases, 2022
Zahra A, Marcos LA.
europepmc   +1 more source

Anti-CD20 Monoclonal Antibody PRO131921 [PDF]

, 2020
openaire   +1 more source

Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination. [PDF]

Int J Hematol, 2022
Inaba T, Okumura K, Maekura C, Muramatsu A, Kobayashi T, Kuroda J, Nukui Y.   +6 more
europepmc   +1 more source

Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination. [PDF]

Int J Hematol, 2022
Inaba T, Okumura K, Maekura C, Muramatsu A, Kobayashi T, Kuroda J, Nukui Y.   +6 more
europepmc   +1 more source

Rituximab: historia, farmacología y perspectivas Rituximab: history, pharmacology and perspectives

Revista Cubana de Hematología, Inmunología y Hemoterapia, 2010
El rituximab integra la primera generación de anticuerpos monoclonales anti CD20 que se utiliza como terapia biológica en los síndromes linfoproliferativos crónicos de estirpe B, en enfermedades autoinmunes y en otras entidades donde hay proliferación de
Edgardo E. Espinosa Estrada, Luis G. Ramón Rodríguez, Lissete Izquierdo Cano, Onel M. Ávila Cabrera, Carlos Hernández Padrón, Edgardo Espinosa Martínez   +5 more
doaj  

Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis. [PDF]

Int J Mol Sci, 2022
Tacke S, Chunder R, Schropp V, Urich E, Kuerten S.   +4 more
europepmc   +1 more source

Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report. [PDF]

Vaccines (Basel), 2022
Calò F, Onorato L, Pisaturo M, Pinto A, Alessio L, Monari C, Minichini C, Arcamone M, Di Fraia A, Atripaldi L, Tiberio C, Coppola N.   +11 more
europepmc   +1 more source

Serum C-X-C Chemokine Ligand 1 Levels in Patients with Systemic Sclerosis: Relationship of Clinical and Laboratory Observations to Anti-CD20 Monoclonal Antibody Administration. [PDF]

Life (Basel), 2022
Kawanabe R, Yoshizaki A, Matsuda KM, Kotani H, Hisamoto T, Norimatsu Y, Kuzumi A, Fukasawa T, Ebata S, Yoshizaki-Ogawa A, Sato S.   +10 more
europepmc   +1 more source